KRTL’s joint venture with CIQ goes beyond securing a 19.98% stake (9.99% each for KRTL Biotech and KRTL International) in 3451.5 acres of land, equating to 689.9 acres. This land, located in a ...

ICON plc, a clinical research organization, expanded its portfolio of artificial intelligence (AI) tools that aim to deliver efficiencies across the clinical trial process, including study startup, ...

Establishes a comprehensive, fully integrated containment solution that seamlessly connects early-phase development through commercial manufacturing.

Indian drugmaker Maithili Life Sciences has received a non-compliant report from the Brussels-based Federal Agency for ...

The pharma sector anticipates enhanced incentives for domestic API and biosimilar production to reduce import dependency. To truly elevate India’s healthcare ecosystem, three critical areas ...

In a report released today, Vikram Purohit from Morgan Stanley maintained a Hold rating on Ascendis Pharma (ASND – Research Report), with a price target of $167.00. The company’s shares closed ...

Exploring sustainable blister packaging from the lens of material selection, quality regulations, machinability, and ...

Special Counsel Says ICON CEO Steve Cutler says trial activity has been “impacted by cautious spending from biopharma customers in both the biotech and large pharma businesses.” The company ...

WEST LAFAYETTE, Ind. — Purdue University, in collaboration with Eli Lilly and Company and Merck & Co. Inc., announced Friday (Jan. 17) the launch of the Young Institute Pharmaceutical Manufacturing ...

Two leading Purdue researchers will discuss the university’s growing role in the next revolution of pharmaceutical manufacturing from 4:30-5:30 p.m. at Westwood, the Purdue president’s residence.

Paul Hudson, CEO of the pharmaceutical firm Sanofi, has an argument for letting AI make top-level decisions in medicine: It has no attachments. Speaking at a panel in Davos on Tuesday, Hudson said ...